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Abstract: Background and Objectives: Foot problems may be considered to be a prevalent condition and
impact the health-related quality of life (QoL). Considering these Spanish-validated tools, the Foot
Health Status questionnaire (FHSQ) may provide a health-related QoL measurement for specific
foot conditions and general status. To date, the domains of the FHSQ and Medical Outcomes Study
Short Form 36 (SF-36) have not been correlated. Therefore, the main aim of this study was to
correlate the domains of the FHSQ and SF-36 in patients with foot problems. Materials and Methods:
A cross-sectional descriptive study was carried out. A sample of 101 patients with foot problems
was recruited. A single researcher collected descriptive data, and outcome measurements (FHSQ
and SF-36) were self-reported. Results: Spearman’s correlation coefficients (rs) were calculated and
categorized as weak (rs = 0.00–0.40), moderate (rs = 0.41–0.69), or strong (rs = 0.70–1.00). In all
analyses, statistical significance was considered with a p-value < 0.01 with a 99% confidence interval.
Statistically significant differences (p < 0.01) were found between all domains of FHSQ and SF-36,
except for the mental health domain of the SF-36 with foot pain, foot function, and general foot
health of the FHSQ, as well as between the vitality domain of the SF-36 and the general foot health
domain of the FHSQ (p > 0.01). Statistically significant correlations varied from week to strong
(rs = 0.25–0.97). The strongest correlations (p < 0.001) were found for physical activity and physical
function (rs = 0.94), vigor and vitality (rs = 0.89), social capacity and social function (rs = 0.97),
and general health domains of the SF-36 and FHSQ. Conclusions: The FHSQ and SF-36 showed
an adequate concurrent validity, especially for the physical activity or function, vigor or vitality,
social capacity or function, and general health domains. Nevertheless, the mental health domain of
the SF-36 should be considered with caution.
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1. Introduction
Foot problems are common disorders, which have reached prevalence rates from 61% to 79% [1–3].
Nevertheless, further studies about the burden of foot problems should be carried out, in order to state
if these conditions comprise a major public health problem [4–6]. Foot problems may frequently be
chronic conditions that appear at primary care consultations, and can reduce the health-related quality
of life (QoL), as well as balance and gait, and increase the risk of falls. Furthermore, foot problems may
be more prevalent and foot surgery costs may be higher in females and older adults [7–9].
Foot problems are frequently complex conditions that affect individuals differently, depending on
presentation, structures involved, and characteristics of symptoms [10]. Up to 24% of people have
diagnosed foot and ankle pathologies, most commonly observed in the forefoot [8].
Foot health-related QoL impairments have been shown in patients with foot problems
regarding specific foot structures, such as hallux valgus [11,12], plantar fasciitis [10,13], or lesser
toe deformities [14], as well as systemic diseases, such as breast cancer [15], diabetes [16], or rheumatoid
arthritis [17].
Multiple Spanish-validated and reliable tools, such as the Foot Health Status Questionnaire
(FHSQ) [10,18–21], Foot Function Index (FFI) [22–24], Manchester Foot Pain and Disability Index
(MFPDI) [25], and Bristol Foot Score (BFS) [26,27], have been used to evaluate specific foot health-related
QoL issues. Of the available tools, the FHSQ has been preferred, due to its high validity and an
included measure of general health [10]. Furthermore, the FHSQ provided a domain for measuring
general health, while the other questionnaires did not [10,18–21].
Considering general health-related QoL, the Medical Outcomes Study Short Form 36 (SF-36)
may be considered as a widely used generic and Spanish-validated scale for evaluating the general
health status of patients [28,29]. Almost four decades ago, health-related QoL tools were developed to
specify patients’ everyday needs, wellbeing, and problems, as well as determine their physical and
psychological status [30].
Considering these Spanish-validated tools, the FHSQ may provide a health-related QoL
measurement for specific foot conditions and general status [10,18–21]. To date, the domains of
the FHSQ and SF-36 have not been correlated [28,29]. Therefore, the main aim of this study was to
correlate the domains of the FHSQ and SF-36 in patients with foot problems. Furthermore, the second
purpose was to evaluate the score differences of the FHSQ and SF-36 between males and females in
our sample.
2. Materials and Methods
2.1. Design
A cross-sectional descriptive study was carried out, in order to correlate the Spanish versions
of the FHSQ [21] and SF-36 [29] in patients with foot problems following the “Strengthening the
Reporting of Observational Studies in Epidemiology” guidelines and checklist [31]. This research was
approved the Ethics Committee of the University of Extremadura (Spain) (number 25/2018, approved
on 6 March 2018). Before the start of the study, all patients voluntarily signed their consent inform
form. Furthermore, the Helsinki Declaration, human rights, and biomedicine statements for the human
research ethical standards were considered.
2.2. Sample
A total sample of 101 patients with foot problems was recruited by a consecutive sampling method
at the Podiatric Medicine and Surgery Clinic for the treatment of foot problems at the University of
Extremadura (Plasencia, Spain) from July to December 2017. The age range varied from 21 to 89 years
old, according to the questionnaire recommendations [28]. The exclusion criteria included prior history
in the patient’s medical record of pathological fractures, trauma, surgery, active systemic neoplasia,
infection, neurologic conditions, and lack of autonomy in daily life activities, as well as refusal to
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sign the informed consent form, inability to understand the instructions to perform the present study,
and nationalities other than Spanish [11].
2.3. Procedure
After applying the inclusion and exclusion criteria, a single trained researcher collected the data
and outcome measurements at the same day. First of all, sociodemographic and descriptive data
were registered. Second, the order of registering the outcome measurements (FHSQ and SF-36) was
randomized by opaque and closed envelopes, in order to determine the first and second questionnaire
provide to each patient. Both questionnaires were administered in person at the Podiatric Medicine
and Surgery Clinic for the treatment of foot problems at the University of Extremadura (Plasencia,
Spain), and were self-reported by each patient.
2.4. Sociodemographic and Descriptive Data
The sociodemographic data included age, sex, weight, height, body mass index (calculated
using Quetelet’s equation: BMI = kg/m2) [32], professional activity (student, freelance, employed
worker, unemployed, or retired), study level (incomplete primary, complete primary, secondary, degree,
or superior degree) and civil status (single, divorced, widowed, couple, or married). In addition,
the foot side (left, right, or both) and foot problem region (forefoot, midfoot, hindfoot, or several
regions) were recorded. Finally, the type of foot problems (hallux valgus or bunions; metatarsalgia;
plantar heel pain, plantar fasciitis or heel spurs; onychocryptosis, toe deformities; Morton’s neuroma;
pes cavus; pes planus; warts; helomas; hyperkeratosis; and generalized foot pain), predisposing factors
(diabetes, obesity, depression, vascular disease, or osteoarticular pathology), and sport participation
were collected.
2.5. FHSQ Outcome Measurement
This Spanish-validated, self-administered tool (FHSQ, 1.03 Version) was comprised of three
sections. Section 1 was composed of 13 items and was divided into four specific, foot health-related
domains: foot function (four items), foot pain (four items), footwear (three items), and general foot
health (two items). A high degree, considering content, criterion, and construct validity (Cronbach α =
0.89–0.95), as well as high retest intraclass correlation coefficient reliability (ICC = 0.74–0.92), was shown
for this section. Section 2 was comprised of four domains reflecting overall health: general health,
physical activity, social capacity, and vigor, whose items were initially adapted from the SF-36. Lastly,
Section 3 was comprised of information about socioeconomic status, comorbidity, and satisfaction,
as well as medical record data, which were included in the descriptive data. Each item provided
several options by a Likert-type ordinal scale, with only one response item as the most appropriate.
The questionnaire provided a score for each domain, which was obtained by a computer program
(score ranged from 0 to 100). Regarding the health-related QoL, the 0 score reflected the worst status,
and the 100 score showed the best status [10,18–21].
2.6. SF-36 Outcome Measurement
The SF-36 (SF-36v2 Standard, Spanish 2.0 Version) was composed of eight health-related domains,
such as physical function, physical role, mental health, vitality, emotional role, social function, body
pain, and general health. This Spanish-validated and reliable tool showed an adequate Cronbach’s
Alpha (Cronbach α = 0.71–0.94), except for the social function scale (Cronbach α = 0.45) and intraclass
correlation coefficient (ICC = 0.58–0.99). Also, each domain presented a score from 0 to 100; the 0 score
reflected the worst QoL, and the 100 score the best health-related QoL [28,29].
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2.7. Sample Size Calculation
A sample size was calculated using the point biserial model correlation with the G*Power
3.1.9.2 software (Heinrich-Heine-Universität Düsseldorf; Düsseldorf, Germany). Indeed, a two-tailed
hypothesis, a moderate effect size of 0.4, anα error probability of 0.01, and a power (1-β error probability)
of 0.95 were used for the sample size calculation. Therefore, a total sample size of 97 subjects was
calculated. Finally, a total sample size of 101 patients was included in this study.
2.8. Statistical Analysis
The Kolmogorov–Smirnov test was utilized to assess normality, and data were determined as
normally distributed if p > 0.05. Considering the quantitative data, the normality test results indicated
that all data were not normally distributed, except for weight and BMI of the demographic data.
Non-parametric data, such as median, interquartile range (IR), and minimum–maximum (range),
were used to describe all data except for the parametric data (weight and BMI), which were described as
mean, standard deviation (SD), and minimum–maximum (range). Regarding the categorical variables
(sex, professional activity, study level, civil status, side, and region of foot problems), frequency and
percentages were applied to describe the data.
With respect to the comparison of quantitative data between males and females for both
tests domains (FHSQ and SF-36), independent Student t-tests were performed to determine
whether statistically significant differences were obtained for the parametric data (weight and BMI),
while Mann–Whitney U tests were applied for the non-parametric data (rest of variables). For the
categorical variables, a Chi-squared test was utilized to determine whether a significant difference was
found between the observed frequencies.
In order to determine the non-parametric correlations between the eight domains (foot function,
foot pain, footwear, general foot health, general health, physical activity, social capacity, and vigor) of
the FHSQ [10,18–21] and the eight domains (physical function, physical role, mental health, vitality,
emotional role, social function, body pain, and general health) of the SF-36, Spearman’s correlation
coefficients (rs) were calculated and categorized as weak (rs = 0.00–0.40), moderate (rs = 0.41–0.69),
or strong (rs = 0.70–1.00) [33,34].
In all analyses, statistical significance was considered with a p-value < 0.01 with a 99% confidence
interval (CI). All analyses were carried out with the available statistical software SPSS version 22.0 for
Windows (SPSS Inc., Chicago, IL, United States).
3. Results
3.1. Sociodemographic and Descriptive Data
A total sample of 101 patients with foot problems, with an age range of 21 to 89 years old,
completed the research. The sample included 83 (82.17%) females and 18 (17.82%) males. Table 1 shows
the demographic and descriptive data of the sample. Despite the fact that the majority of the patients
were overweight (BMI = 27.51 ± 4.82 kg/m2), the only statistically significant differences (p < 0.01)
between males and females were shown for height and weight, and not for age, BMI, foot problem (FP)
region, or side (p > 0.01).
Table 2 shows the social characteristics of the sample. There were not any statistically significant
differences (p > 0.01) for the studied social characteristics, such as professional activity, study level,
and civil status.
Regarding the descriptive data for the foot problems, the foot problem percentages (frequency)
presented by the patients of the sample were 15.84% (n = 16) hallux valgus or bunions; 20.79%
(n = 21) metatarsalgia; 13.86% (n = 14) plantar heel pain, plantar fasciitis, or heel spurs; 11.88% (n = 12)
onychocryptosis; 10.89% (n = 11) toe deformities; 0.99 % (n = 1) Morton’s neuroma; 9.90% (n = 10)
pes cavus; 2.87% (n = 3) pes planus; 1.98% (n = 2) warts; 4.95% (n = 5) helomas; and 4.95% (n = 5)
hyperkeratosis; as well as (n = 17) generalized foot pain. In addition, the percentages (frequency) of
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patients with foot problems who presented predisposing factors were 21.78 % (n = 22) vascular disease,
14.85 % (n = 15) osteoarticular pathology, 8.91% (n = 9) diabetes, 2.97% (n = 3) obesity, and 1.98% (n = 2)
depression. Furthermore, 0.69% (n = 7) of these patients reported sport participation.
Table 1. Demographic and descriptive data of the sample.
Demographic and Descriptive Data Total Groupn = 101
Male
n = 18
Female
n = 83 p-Value
Age (years) 64.00 ± 23.50(21–89)
59.50 ± 26.25
(21–89)
65.00 ± 22.00
(21–87) 0.607
†
Weight (kg) 72.46 ± 13.114(33–107)
81.11 ± 14.04
(59–104)
70.59 ± 12.72
(33–107) 0.002 *
Height (cm) 161.00 ± 10.00(148–187)
170.00 ± 10.00
(162–187)
160.00 ± 9.00
(148–174) <0.001
†
BMI (kg/m2)
27.51 ± 4.824
(13.22–38.83)
27.20 ± 3.9
(21.94–36.06)
27.58 ± 5.00
(13.22–38.83) 0.765 *
FP region
Forefoot 67 (66.3%) 13 (72.2%) 54 (65.0%)
0.498 ‡
Midfoot 2 (2.0%) 1 (5.5%) 1 (1.2%)
Hindfoot 12 (11.9%) 1 (5.5%) 11 (13.2%)
Several 20 (19.8%) 3 (16.6%) 17 (20.4%)
FP side
Left 14 (13.9%) 4 (22.2%) 10 (12.0%)
0.483 ‡Right 16 (15.8%) 2 (11.1%) 14 (12.86%)
both sides 71 (70.3%) 12 (66.6%) 59 (71.08%)
BMI: body mass index; FP: foot problem. * Mean ± standard deviation, range (min–max) and Student´s t-test for
independent samples were applied. † Median ± interquartile range, range (min–max) and Mann–Whitney U test
were used. ‡ Frequency, percentage (%), and Chi-squared test (χ2) were utilized. In all the analyses, p < 0.01 (with a
99% confidence interval) was considered statistically significant.
Table 2. Social characteristics of the sample.
Social Characteristics Total Groupn = 101
Male
n = 18
Female
n = 83 p-Value
‡
Professional activity
Student 4 (4%) 1 (5.5%) 3 (3.6%)
0.270
Freeland 8 (7.9%) 2 (11.1%) 6 (7.2%)
Employed 23 (22.8%) 7 (38.8%) 16 (19.2%)
unemployed 7 (6.9%) 0 (0.0%) 7 (8.4%)
Retired 59 (58.4%) 8 (44.4%) 51 (61.45)
Study level
I. primary 28 (27.7%) 1 (5.5%) 27 (32.5%)
0.033
C. primary 36 (35.6%) 8 (44.4%) 28 (33.7%)
Secondary 21 (20.8%) 4 (22.2%) 17 (20.4%)
Degree 11 (10.9%) 2 (11.1%) 9 (10.8%)
S. degree 5 (5.0%) 3 (16.6%) 2 (2.4)
Civil status
Single 16 (15.8%) 1 (5.5%) 15 (18.0%)
0.090
Divorced 3 (3.0%) 1 (5.5%) 2 (2.4%)
Widowed 23 (22.8%) 1 (5.5%) 22 (26.5%)
Couple 2 (2.0%) 0 (0.0%) 2 (2.4%)
Married 57 (56.4%) 15 (83.33%) 42 (50.6%)
C: complete; I: incomplete; S: superior. ‡ Frequency, percentage (%), and Chi-squared test (χ2) were utilized. In all
the analyses, p < 0.01 (with a 99% confidence interval) was considered statistically significant.
3.2. FHSQ by Sex Distribution
The FHSQ scores between males and females with foot problems are shown in Table 3. Females
with foot problems showed statistically significant differences (p < 0.01) for lower scores in the
domains of foot pain and general health. The rest of domains did not show statistically significant
differences (p > 0.01).
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Table 3. Comparisons of FHSQ scores between males and females with foot problems.
FHSQ Domains.
Total group
Median ± IR
(Range)
n = 100
Male
Median ± IR
(Range)
n = 18
Female
Median ± IR
(Range)
n = 83
p-value Male vs. Female †
Foot pain 48.12 ± 37.50(0–90)
63.43 ± 42.66
(25–90)
41.87 ± 41.25
(0–87) 0.009
Foot function 68.75 ± 46.88(0–100)
78.12 ± 45.31
(25–100)
68.75 ± 50.00
(0–100) 0.562
Footwear 25.00 ± 50.00(0–100)
25.00 ± 54.17
(0–100)
25.00 ± 50.00
(0–100) 0.674
General foot
health
25.00 ± 21.25
(0–85)
25.00 ± 38.13
(0–72)
25.00 ± 12.50
(0–85) 0.063
General health 60.00 ± 45.00(0–100)
85.00 ± 42.50
(20–100)
60.00 ± 50.00
(0–100) 0.002
Physical activity 72.22 ± 47.22(55–100)
80.55 ± 27.68
(22–100)
66.66 ± 50.00
(5–100) 0.097
Social capacity 87.50 ± 37.50(0–100)
93.75 ± 28.13
(37–100)
87.50 ± 37.50
(0–100) 0.346
Vigor 62.50 ± 31.25(0–100)
68.75 ± 37.50
(12–93)
56.25 ± 37.50
(0–100) 0.087
IR: interquartile range; FHSQ: Foot Health Status Questionnaire. † Median ± interquartile range, range (min–max)
and Mann–Whitney U test were used. In all the analyses, p < 0.01 (with a 99% confidence interval) was considered
statistically significant.
3.3. SF-36 by Sex Distribution
The SF-36 scores between males and females with foot problems are shown in Table 4. Females
with foot problems showed statistically significant differences (p < 0.01) for lower scores in the domain
of general health. The rest of the domains did not show statistically significant differences (p > 0.01).
Table 4. Comparisons of SF-36 scores between males and females with foot problems.
SF-36 Domains
Total group
Median ± IR
(Range)
n = 100
Male
Median ± IR
(Range)
n = 18
Female
Median ± IR
(Range)
n = 83
p-value Male vs. Female †
Physical function 75.00 ± 42.50(5–100)
85.00 ± 27.50
(25–100)
65.00 ± 45.00
(5–100) 0.059
Physical role 00.00 ± 00.00(0–100)
00.00 ± 00.00
(0–100)
00.00 ± 25.00
(0–100) 0.064
Mental health 00.00 ± 00.00(0–100)
00.00 ± 00.00
(0–66)
00.00 ± 00.00
(0–100) 0.412
Vitality 56.30 ± 31.20(0–100)
68.80 ± 37.50
(25–93)
56.30 ± 31.20
(0–100) 0.123
Emotional role 65.00 ± 25.00(20–85)
70.00 ± 21.25
(40–85)
65.00 ± 25.00
(20–85) 0.257
Social function 87.50 ± 42.00(0–100)
93.75 ± 28.13
(12–100)
87.50 ± 46.00
(0-100) 0.270
Body Pain 37.50 ± 25.00(0–100)
47.45 ± 45.63
(12–100)
37.50 ± 25.00
(0–100) 0.090
General health 50.00 ± 25.00(0–100)
80.00 ± 27.50
(35–95)
55.00 ± 35.00
(0–95) 0.001
IR: interquartile range; SF-36: Medical Outcomes Study Short Form 36. † Median ± interquartile range, range
(min–max) and Mann–Whitney U test were used. In all the analyses, p < 0.01 (with a 99% confidence interval) was
considered statistically significant.
3.4. Correlations Between FHSQ and SF-36 Domains
The Spearman’s correlations between FHSQ and SF-36 domains are shown in Table 5. Statistically
significant differences (p < 0.01) were found between all domains of the FHSQ and SF-36, except for
the mental health domain of the SF-36 with the foot pain, foot function, and general foot health of
the FHSQ, as well as between the vitality domain of the SF-36 and the general foot health domain of
the FHSQ (p > 0.01). Statistically significant correlations varied from weak to strong (rs = 0.25–0.97).
The strongest correlations (p < 0.001) were found for physical activity and physical function (rs = 0.94),
vigor and vitality (rs = 0.89), social capacity and social function (rs = 0.97), and the general health
domains of the SF-36 and FHSQ.
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Table 5. Spearman´s correlations between FHSQ and SF-36 scores in patients with foot problems.
FHSQ Domains SF-36 Domains: rs (p-value) *
Physical Function Physical Role Mental Health Vitality Emotional Role Social Function Body Pain General Health
Foot pain 0.29 (0.003) −0.36 (<0.001) −0.13 (0.177) 0.33 (0.001) 0.25 (0.009) 0.30 (0.002) -0.45 (<0.001) -0.39 (<0.001)
Foot function 0.52 (<0.001) −0.40 (<0.001) −0.21 (0.030) 0.51 (<0.001) 0.42 (<0.001) 0.49 (<0.001) 0.50 (<0.001) 0.49 (<0.001)
Footwear 0.32 (0.001) −0.28 (0.004) −0.34 (<0.001) 0.44 (<0.001) 0.27 (0.006) 0.31 (0.001) 0.28 (0.003) 0.33 (0.001)
General foot health 0.33 (0.001) −0.30 (0.002) −0.13 (0.174) 0.24 (0.013) 0.32 (0.001) 0.32 (0.001) 0.41 (<0.001) 0.38 (<0.001)
General health 0.69 (<0.001) −0.51 (<0.001) −0.33 (0.001) 0.56 (<0.001) 0.59 (<0.001) 0.51 (<0.001) 0.41 (<0.001) 0.91 (<0.001)
Physical activity 0.94 (<0.001) −0.49 (<0.001) −0.44 (<0.001) 0.62 (<0.001) 0.56 (<0.001) 0.51 (<0.001) 0.50 (<0.001) 0.58 (<0.001)
Social capacity 0.45 (<0.001) −0.44 (<0.001) −0.31 (0.002) 0.55 (<0.001) 0.56 (<0.001) 0.97 (<0.001) 0.44 (<0.001) 0.54 (<0.001)
Vigor 0.61 (<0.001) −0.56 (<0.001) −0.37 (<0.001) 0.89 (<0.001) 0.47 (<0.001) 0.57 (<0.001) 0.50 (<0.001) 0.56 (<0.001)
FHSQ: Foot Health Status Questionnaire; rs: Pearson´s correlations coefficient; SF-36: Medical Outcomes Study Short Form 36. * Pearson´s correlations coefficient (rs) and p-value were
applied. In all the analyses, p < 0.01 (with a 99% confidence interval) was considered statistically significant.
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4. Discussion
To the authors’ knowledge, this research may be considered as the first study to show the
concurrent validity between the FHSQ [10,18–21] and SF-36 [28,29] domains in patients with foot
problems. Gender differences were in line with a prior study of ours, which assessed FHSQ scores in
patients with foot problems [35], and these differences were in accordance with our findings using the
SF-36. The correlation between both questionnaires provides the concurrent validity of each domain to
the current research literature, and supports the use of the FHSQ as an adequate tool to measure QoL
in relation to general health and in conjunction with specific foot health, using only a questionnaire.
This issue may be considered as an advantage with respect to the other available Spanish-validated
questionnaires to evaluate specific foot-health-related QoL, such as the FFI [22–24], MFPDI [25] and
BFS [26,27].
The high prevalence (72.1%) of foot problems in the population requires health-related QoL
research. According to our study, foot pain tends to be more prevalent in females than in males [30,36].
In line with our research, prior studies have shown that QoL related to foot health presents lower
scores, showing a worse QoL in females than in males [37]. Furthermore, specific foot problems,
such as hallux valgus, calcaneal apophysitis, foot arch height, heel pain, or onychomycosis have been
shown to reduce the QoL related to foot health, and these results coincide with our studies [13,38–41].
Thus, foot problems impair the QoL related to foot and general health—and specifically, women with
foot problems present a negative QoL impact related to foot and general health with respect to men,
except in the overall health and social capacity domains, which appear to be linked to the presence of
foot conditions and the aging process [35,42].
According to the concurrent validity, the mental health domain of the SF-36 showed the worst
correlations. This fact may be due to the fact that the FHSQ did not include any specific domain
for mental health. Nevertheless, the strongest correlations were determined for physical activity or
function, vigor or vitality, social capacity or function, and general health domains. The possible reason
for this may be due initially to Section 2 of the FHSQ, which was based on the domains of the SF-36.
Nevertheless, this is the first study to determine their concurrent validity [10,18–21,28,29].
Future studies should address the need to use and study scores that are not limited just to the
functionality of the foot. Despite the fact that the SF-36 has been widely used to determine general
quality of life related to foot disorders [43–45], the short form (SF)-12 score has also been used to
compare general health-related QoL outcomes after foot and ankle interventions [46–48]. Nevertheless,
we used the SF-36, since Section 2 of the FHSQ was initially adapted from the SF-36, and this study
was necessary in order to correlate both domains [10,18–21].
Several limitations of this study should be acknowledged. A sample of diverse patients from
other countries could be helpful to improve the strength of this study. This study only evaluated the
concurrent validity between FHSQ and SF-36 in Spanish patients with foot problems. Although foot
problems are very common in the population [49], this study should be expanded to other regions
with more frequent musculoskeletal problems, such as the lower back, neck, or shoulder regions [50].
In addition, the used consecutive sampling method may present a bias, and a randomized sampling
should be used in future studies. According to our prior affirmations, we used the SF-36, but the SF-12
should be correlated with the FHSQ in futures studies, because SF-12 may be considered a reliable
and summarized questionnaire of the SF-36, and has been widely used to evaluate the health-related
QoL of patients with foot and ankle disorders [46–48]. Finally, the impact of the correlation between
the different foot pathologies, including different congenital and acquired or traumatic disorders and
degenerative pathologies, was not analyzed in the present study, because our sample was not balanced
enough to carry out these comparisons. The authors encourage researchers to perform future studies
addressing health-related QoL impacts under these different conditions.
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5. Conclusions
The FHSQ and SF-36 showed an adequate concurrent validity, especially for physical activity
or function, vigor or vitality, social capacity or function, and general health domains. Nevertheless,
the mental health domain of the SF-36 should be considered with caution.
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